|
 |
|
The at the Beth Israel Deaconess Medical Center promotes the public’s use of BIDMC technology for society’s benefit and fosters alliances with industry through collaboration and licensing agreements, while generating unrestricted income to support research.
For information on intellectual property at BIDMC, please contact:
Jason Felsch, Ph.D.
Senior Associate
Beth Israel Deaconess Medical Center
Technology Ventures Office
330 Brookline Avenue, BR-0244
Boston, MA 02215
; fax:
|
|

|
|
Apparatus and method for forming an electrophoretic gel having a polymer. The apparatus has at least two sealed compartments, with separate inner volumes. The inner volumes are separated from each other by at least one burstable seal. In one inner volume is a monomer which can be polymerized to form the polymer. In other inner volume is a catalyst. Bursting of the burstable seal allows the monomer and catalyst to contact each other and, in conjuction with any other necessary components held within the apparatus, to form a liquid medium in the apparatus which will then form the electrophoretic gel under suitable conditions.
|
 |
The present invention is directed to a non-isotopic methods for the in vitro and in vivo detection of hydroxyapatite-positive cells and structures.
|
 |
The present invention provides reagents and methods for diagnosis, detection and treatment of cancers (for example, prostate cancers). In particular, the invention provides methods to generate various functionalized PSMA ligands, and their uses in diagnosis, detection, imaging, and treatment of prostate cancers, especially those overexpressing PSMA.
|
 |
|
|
|
|
 |